Oxytetracycline calcium - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for oxytetracycline calcium and what is the scope of patent protection?
Oxytetracycline calcium
is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for oxytetracycline calcium.
Summary for oxytetracycline calcium
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 94 |
| Clinical Trials: | 1 |
| Patent Applications: | 7,063 |
| DailyMed Link: | oxytetracycline calcium at DailyMed |
Recent Clinical Trials for oxytetracycline calcium
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for oxytetracycline calcium
US Patents and Regulatory Information for oxytetracycline calcium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | TERRAMYCIN | oxytetracycline calcium | SYRUP;ORAL | 060595-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
